(Q56908908)

1

object named as

Theoharis C Theoharides

0 references

author name string

Kristine Whitmore

2

0 references

Edward Stanford

3

0 references

Robert Moldwin

4

0 references

Michael P O'Leary

Expert Opinion on Pharmacotherapy

5

0 references

language of work or name

English

0 references

publication date

12 November 2008

0 references

published in

0 references

volume

9

0 references

issue

17

0 references

page(s)

2979-2994

0 references

cites work

The management of interstitial cystitis: an update

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Treatment approaches for painful bladder syndrome/interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Interstitial cystitis: a chronic pelvic pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Current management of interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

The epidemiology of interstitial cystitis: is it time to expand our definition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Interstitial cystitis, chronic nonbacterial prostatitis and chronic pelvic pain syndrome in men: a common and frequently identical clinical entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Assessing urgency in interstitial cystitis/painful bladder syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

A prospective, double-blind, randomized cross-over study evaluating changes in urinary pH for relieving the symptoms of interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Evidence-based criteria for pain of interstitial cystitis/painful bladder syndrome in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Increased prevalence of interstitial cystitis in women with detrusor overactivity refractory to anticholinergic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

The relationship between fibromyalgia and interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Risk of irritable bowel syndrome and depression in women with interstitial cystitis: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Interstitial Cystitis: Cost, treatment and co-morbidities in an employed population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Interstitial cystitis and panic disorder: a potential genetic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Prevalence of interstitial cystitis symptoms in women: a population based study in the primary care office.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Development of glomerulations in younger women with interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Factors predisposing women to chronic pelvic pain: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Characterization of a clinical cohort of 87 women with interstitial cystitis/painful bladder syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Correlation between 2 interstitial cystitis symptom instruments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Responsiveness of symptom scales for interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Urinary and Serologic Markers forInterstitial Cystitis: An Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

APF, HB-EGF, and EGF biomarkers in patients with ulcerative vs. non-ulcerative interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Symptoms and cystoscopic findings in patients with untreated interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Urinary uronate and sulfated glycosaminoglycan levels: markers for interstitial cystitis severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Changes in urine markers and symptoms after bladder distention for interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Localization and expression of inducible nitric oxide synthase in biopsies from patients with interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Future research needs for the definition/diagnosis of interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Discovery of morphological subgroups that correlate with severity of symptoms in interstitial cystitis: a proposed biopsy classification system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Critical role of mast cells in inflammatory diseases and the effect of acute stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Prevalence of interstitial cystitis in first-degree relatives of patients with interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Absence of bacterial and viral DNA in bladder biopsies from patients with interstitial cystitis/chronic pelvic pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Recognition sites for microbes and components of the immune system on human mast cells: relationship to CD antigens and implications for host defense.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Monocyte chemoattractant protein-1 production by human detrusor smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Altered expression of bladder mast cell growth factor receptor (c-kit) in interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Possible mechanisms inducing glomerulations in interstitial cystitis: relationship between endoscopic findings and expression of angiogenic growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Abnormal urinary potassium metabolism in patients with interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Urinary chondroitin sulfates, heparan sulfate and total sulfated glycosaminoglycans in interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Plasma extravasation in the skin and pelvic organs evoked by antidromic stimulation of the lumbosacral dorsal roots of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Acute stress and intravesical corticotropin-releasing hormone induces mast cell dependent vascular endothelial growth factor release from mouse bladder explants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Corticotropin releasing factor: a mediator of emotional influences on bladder function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Comorbidity of interstitial cystitis with other unexplained clinical conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

New agents for the medical treatment of interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Pharmacologic management of painful bladder syndrome/interstitial cystitis: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Efficacy of pentosan polysulfate in the treatment of interstitial cystitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Hydroxyzine inhibits neurogenic bladder mast cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Hydroxyzine therapy for interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Menstrual cycle affects bladder pain sensation in subjects with interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Immunomodulators for treatment of interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Efficacy of prednisone for severe refractory ulcerative interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

A pilot open label study of Cystoprotek in interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Nitric oxide as an objective marker for evaluation of treatment response in patients with classic interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

A randomized double-blind placebo-controlled crossover trial of the efficacy of L-arginine in the treatment of interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Tumor necrosis factor promotes differential trafficking of bladder mast cells in neurogenic cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis: discomfort, side-effects and treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Dyspareunia response in patients with interstitial cystitis treated with intravesical lidocaine, bicarbonate, and heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

A rational combination of intravesical and systemic agents for the treatment of interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Sacral neuromodulation decreases narcotic requirements in refractory interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Transdermal posterior tibial nerve laser therapy is not effective in women with interstitial cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Treatment of bladder pain syndrome/interstitial cystitis 2008: can we make evidence-based decisions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Mast cells as targets of corticotropin-releasing factor and related peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor–like growth factor, and epidermal growth factor as urine markers for interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845

CNS INDUCED NEUROGENIC CYSTITIS IS ASSOCIATED WITH BLADDER MAST CELL DEGRANULATION IN THE RAT

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802519845